دبي، الإمارات العربية المتحدة – EQS Newswire – 4 أبريل 2025 – آي سون إكسبيريانسز (www.iSONXperiences.com)، الشركة العالمية الرائدة في مجال تجربة العملاء الرقمية المدعومة بالذكاء الاصطناعي وحلول التعهيد الخارجي، عيَّنت ريكاردو لانجويدر رئيسًا تنفيذيًا للمبيعات. سينضم ريكاردو إلى اللجنة التنفيذية، وسيقود التوسع العالمي للشركة ونمو إيراداتها وشراكاتها الاستراتيجية.بخبرة تمتد لأكثر من 25 عامًا في مجال إدارة الشركات وريادة الأعمال الدولية، يُعد ريكاردو خبيرًا مرموقًا في مجالات تجربة العملاء والتحول الرقمي والتعهيد الخارجي. شغل ريكاردو مناصب قيادية في شركات عالمية مثل ألوريكا، وماجوريل، وإي إكس إل، وستريم، وفيليبس حيث قاد مبادرات نمو وتحوِّل عالية التأثير. يُعد ريكاردو من أبرز داعمي نقل الأعمال إلى الخارج وإلى المناطق المجاورة في أفريقيا، ولذلك أدى دورًا محوريًا في ترسيخ مكانة المنطقة بصفتها مركزًا لحلول تجربة العملاء عالية الجودة ومنخفضة التكلفة.
قال فيتول كواترا، الرئيس التنفيذي لشركة آي سون إكسبيريانسز: “يسعدنا الترحيب بريكاردو في آي سون إكسبيريانسز”،وأضاف قائلًا: “مع استمرارنا في تطوير حلول تجربة العملاء الرقمية المدعومة بالذكاء الاصطناعي وحلول التعهيد الخارجي، ستكون لخبرة ريكاردو في نقل عمليات تجربة العملاء إلى أفريقيا ورؤيته الاستراتيجية أهمية بالغة. ستعزز قيادته توسعنا في السوق، وستعود بفائدة كبيرة على عملائنا، وستعزز دور أفريقيا بصفتها مساهمًا رئيسيًا في مجال تجربة العملاء“.
أدى ريكاردو دورًا حيويًا في جذب العملاء والاستثمارات من مختلف أنحاء العالم إلى أفريقيا، مؤكدًا على إمكاناتها بصفتها مركزًا عالميًا في مجالي تجربة العملاء وخدمات التعهيد الخارجي. خبرة ريكاردو في هيكلة نماذج التسليم الخارجي وتوسيع نطاق عمليات التعهيد الخارجي تتلاءم مع سعي شركة آي سون إكسبيريانسز نحو تعزيز الابتكار والكفاءة والتأثير الاقتصادي المستدام.
قال ريكاردو لانجويدر، الرئيس التنفيذي للمبيعات: “يسعدني الانضمام إلى آي سون إكسبيريانسز في هذه المرحلة التحوّلية“. أضاف ريكاردو قائلًا: “تتميز الشركة بالتزامها بالابتكار في مجال تجربة العملاء المدعومة بالذكاء الاصطناعي، ومكانتها الكبيرة في أفريقيا، ونهجها الذي يركزعلى إرضاء العملاء. أتطلع إلى الاستفادة من خبرتي في مجال نقل الأعمال إلى الخارجوإلى المناطق المجاورة لدفع عجلة نمو الأعمال، وتوسيع نطاق نفوذها العالمي، والمساهمة في الفرص الاقتصادية في جميع أنحاء المنطقة“.
يُؤكد تعيين ريكاردو التزام آي سون إكسبيريانسز باجتذاب أفضل الكفاءات في المجال، وتعزيز ريادتها في مجال حلول تجربة العملاء المدعومة بالذكاء الاصطناعي في مختلف الأسواق العالمية.
وزعتها مجموعة إيه بي أو نيابةً عن آي سون إكسبيريانسز.
نبذة عن آي سون إكسبيريانسز
تُعد آي سون إكسبيريانسز شركة عالمية رائدة في مجال حلول تجربة العملاء المدعومة بالذكاء الاصطناعي، وهي تمد الشركات بأدوات التشغيل الآلي الذكي، ورؤى مستندة إلى البيانات، وحلول التحول الرقمي. تدير آي سون أعمالها في 22 دولة، ويعمل بها 18,000 اختصاصي، وهي متخصصة في مجالات الاتصالات، والخدمات المصرفية والمالية والتأمين، والرعاية الصحية، والتكنولوجيا المالية، وتجارة التجزئة، وبذلك تساهم في نمو الأعمال، والكفاءة التشغيلية، وتدعم الابتكار في مجال تجربة العملاء في جميع أنحاء أفريقيا، والشرق الأوسط، والمملكة المتحدة، وفرنسا، والولايات المتحدة، والهند.
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neumora Therapeutics, Inc. (NASDAQ: NMRA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with Neumora’s September 2023 initial public offering (the “IPO”), of the important April 7, 2025 lead plaintiff deadline in the securities class action first filed by the firm.
SO WHAT: If you purchased Neumora common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Neumora class action, go to https://rosenlegal.com/submit-form/?case_id=34655 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 7, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, the Offering Documents contained false and/or misleading statements and/or failed to disclose that: (1) in order for Neumora to justify conducting its Phase Three Program, Neumora was forced to amend BlackThorn’s original Phase Two Trial inclusion criteria to include a patient population with moderate to severe major depressive disorder (“MDD”) to show that Navacaprant offered a statistically significant improvement in treating MDD; (2) and to that same end, Neumora also added a prespecified analysis to the Phase Two statistical analysis plan, focusing on patients suffering from moderate to severe MDD; and (3) the Phase Two Trials lacked adequate data, particularly in regards to the patient population size and the ratio of male to female patients within the patient population, to be able to accurately predict the results of the KOASTAL-1 study. When the true details entered the market, the lawsuit claims that investors suffered damages.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected] www.rosenlegal.com
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, both dates inclusive (the “Class Period”), of the important April 15, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.
SO WHAT: If you purchased TransMedics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the TransMedics class action, go to https://rosenlegal.com/submit-form/?case_id=22793 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 15, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue; (2) TransMedics engaged in unsafe practices and hid safety issues and generally lacked safety oversight; (3) the foregoing subjected TransMedics to heightened risk of scrutiny and regulatory risk; and (4) as a result, defendants’ statements about TransMedics’ business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected] www.rosenlegal.com
AKWEL (FR0000053027, AKW, PEA-eligible), parts and systems manufacturer for the automotive and heavy-vehicle industry, specialist in fluid management, mechanisms and E-powertrain parts, posted its 2024 annual results.
Consolidated data – in € millions
2024
2023
Var. in %
Revenue
989.0
1066.4
-7.3%
EBITDA
87.2
101.9
-14.4%
Current operating income
38.4
61.0
-37.1%
Operating income
39.7
49.3
-19.4%
Financial income
1.4
0.3
–
Net result (group share)
24.2
35.7
-32.3%
Inflationary pressures on raw materials and components, but especially on payroll, still weigh on current operating profit in the context of a decline in activity while essential expenditure is still being maintained to build the Group’s future. EBITDA decreased by -14.4% to €87.2M and current operating income decreased by -37.1% to €38.4M. After an income tax expense of €16.6M, the net income attributable to the Group reached €24.2M.
The operating cash flow amounted to €95.7M, up 49.7%. Net investments remained high in 2024 at €40.3M, focusing in particular on safety issues, product adaptation to electric motors and hydrogen engines and on product competitiveness by integrating the manufacture of certain components. AKWEL generated a positive net cash position at the end of the period of €133.4M, compared to €105M at the end of 2023.
Significant progress was recorded in terms of CSR, including a further decrease in the frequency of accidents at work, a reduction in water consumption and a decrease of -36% in carbon emissions compared to 2021.
The evolution of the world market and the delays in the start of production and sales of electric vehicles should lead to a decline in activity in 2025 comparable to that of 2024. In this context, the Group continues to adapt to a market undergoing transformation by adjusting its production costs, strengthening its technical and technological capabilities and by developing the agility of its organization.
An independent family business, trading on Euronext Paris, AKWEL is a parts and systems manufacturer for the automotive and heavy-vehicle industry, and a specialist in fluid management, mechanisms and structural parts for electric vehicles. The Group achieves this with their first-rate industrial and technological know-how in mastering the application and processing of materials (plastic, rubber, metal) and mechatronic integration.
Operating in 20 countries across 5 continents, AKWEL employs 8,600 people worldwide.
A groundbreaking new book published today presents a transformative solution to the global migration crisis: self-governed urban prosperity hubs where migrants and refugees can rebuild their lives and contribute to society
ZURICH, April 03, 2025 (GLOBE NEWSWIRE) — As conventional approaches fail, Free Global Cities: The Future Leaders in Migration and Public Governance proposes a bold alternative — autonomous cities designed to foster economic opportunity, education, and innovation. Edited by Dr. Christian H. Kälin, Chairman of the Swiss non-profit humanitarian organisation Andan Foundation, the book brings together a wide range of distinguished global thought leaders to explore how self-sustaining autonomous cities can offer displaced populations the opportunity to build new lives.
Published by Bloomsbury, the book challenges global leaders and citizens to rethink how the displacement of people forced from their homes due to conflict, persecution and climate change can be turned into opportunity, blending forward-thinking ideas with actionable policy and profitable investment.
“Through these chapters, we explore a pragmatic solution to the global refugee and migration crisis — the creation of self-governing sub-national entities where displaced individuals can live, work, and start businesses, ultimately becoming active contributors to the local economy. By transforming migration from a problem into an engine of opportunity, these free global cities create pathways for refugees to rebuild their lives while driving economic growth and social stability,” says Kälin.
A Vision for Self-Sustaining Communities
The book features contributions from 35 leading international experts, including Michael Møller, former Under-Secretary-General of the United Nations; Dr. Titus Gebel, Founder and CEO of Tipolis; Professor Dr. Dr. h.c. Paul Robert Vogt, Founder and President of EurAsia Heart; Mohamed Nasheed, former President of the Maldives and Secretary-General of the Climate Vulnerable Forum; Dr. Parag Khanna, Founder and CEO of AlphaGeo; Simon Anholt, independent policy adviser and author; and Mikael Ribbenvik Cassar, Deputy Executive Director of the EU Agency for Asylum.
Together, these experts provide a comprehensive roadmap for the future of migration governance, illustrating how Free Global Cities can drive prosperity, stability, and development.
Kälin explains that “rather than perceiving refugees as recipients of benevolence or burdens on host communities, it recognizes them as agents of change, capable of contributing their skills, talents, and perspectives if given the opportunity in a new home. By fostering environments of inclusivity and innovation, Free Global Cities seek to harness the untapped potential of displaced people, transforming them from victims of circumstance into architects of their own futures.”
Contributor Michael Møller, former Under-Secretary-General of the UN, says, “the concept of Free Global Cities as innovative and rapid solutions to intertwined existential challenges makes eminent sense because it involves a fundamental and logical rethinking of the very concept of cities and their potential to provide a comprehensive path forward.”
Prof. Kishore Mahbubani, Distinguished Fellow at the Asia Research Institute of the National University of Singapore and former President of the United Nations Security Council, points out in his commentary that “unless humanity as a whole comes together to cooperate and find creative, innovative solutions, many societies will be torn apart by stresses generated by explosive migration. (…) Fortunately, there is an innovative solution to global migration that can get politicians re-elected after carrying it out. Here, this innovative solution is called Free Global Cities.”
A Good Future for All
As migration numbers continue to grow, governments and international organizations face mounting pressure to develop solutions that are not only effective but also politically feasible. The Free Global Cities model responds to the anticipated increase in migration. These cities are scalable and can be implemented to offer displaced people the chance to build new futures for themselves, while also providing lasting benefits to the nations that host them.
Mohamed Nasheed, former President of the Maldives and current Secretary-General of the Climate Vulnerable Forum, says in his contribution that “by prioritising inclusive policies and effective border management strategies, nations and indeed future Free Global Cities can enhance their resilience against global challenges, promote sustainable development, and mitigate the negative impacts of forced migrations.”
In his chapter, Dr. Parag Khanna, Founder and CEO of AlphaGeo, points out that today’s unfolding migration waves are not just about people on the move. “They are part of a far grander story, an epochal shift in the organisation of global civilisation. We are entering a window of opportunity — the last window of opportunity — to ensure maximum survival of our species. To succeed, we will have to do more than tinker with immigration policy. Rather, we need a global strategy to reprogramme the geography of human civilisation towards sustainable urban habitats in climate-resilient locations.”
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the “Class Period”), of the important April 14, 2025 lead plaintiff deadline.
SO WHAT: If you purchased Merck securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Merck class action, go to https://rosenlegal.com/submit-form/?case_id=34975 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 14, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants provided investors with material information concerning Merck’s expected revenue of $11 billion from sales of Gardasil by 2030. Defendants’ statements included, among other things, confidence in Merck’s purported ability to utilize successful consumer activation and education efforts on the benefits of Gardasil in order to drive demand and capitalize on eligible populations for vaccination, resulting in confidently optimistic reports and forecasts of Gardasil’s growth in China. Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Gardasil’s demand in China; notably, that Merck lacked visibility into demand for Gardasil in China among eligible and otherwise targeted populations, resulting in the inflated inventory of its distributor, Zhifei. When the true details entered the market, the lawsuit claims that investors suffered damages.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected] www.rosenlegal.com
GlobeNewswire Distribution ID 1001077495